Cefaclor
Cefaclor.JPG

Cefaclor

CLINICAL USE

Antibacterial agent

DOSE IN NORMAL RENAL FUNCTION

250 mg every 8 hours (dose may be doubled for more severe infections – maximum 4 g daily)

PHARMACOKINETICS

  • Molecular weight                           :385.8
  • %Protein binding                           :25
  • %Excreted unchanged in urine     : 60–85
  • Volume of distribution (L/kg)       :0.24–0.35
  • half-life – normal/ESRD (hrs)      :0.5–0.9/2.3–2.8

    DOSE IN RENAL IMPAIRMENT

    GFR (mL/MIN)

  • 20 to 50     : Dose as in normal renal function
  • 10 to 20     : Dose as in normal renal function
  • <10           : 250 mg every 8 hours

    DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES

  • CAPD                :Dialysed. 250 mg every 8–12 hours
  • HD                     :Dialysed. 250–500 mg every 8 hours
  • HDF/high flux   :Dialysed. 250–500 mg every 8 hours
  • CAV/VVHD      :Dialysed. Dose as in normal renal function

    IMPORTANT DRUG INTERACTIONS

    Potentially hazardous interactions with other drugs
  • Anticoagulants: effects of coumarins may be enhanced

    ADMINISTRATION

    Reconstition

    Route

    Oral

    Rate of Administration

    Comments

    OTHER INFORMATION

    Cefaclor associated with protracted skin reactions.



    See how to identify renal failure stages according to GFR calculation

    See how to diagnose irreversible renal disease

    Home

  • other drugs